Cullinan Therapeutics, Inc. CGEM Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $75.08M-15.0% | $88.33M-14.5% | $103.34M+41.9% | $72.82M-5.0% | $76.66M-7.7% | ||
| $276.8M-4.4% | $289.56M+26.3% | $229.26M+19.0% | $192.66M-15.2% | $227.17M-28.1% | ||
| $361.41M-6.6% | $386.76M+13.0% | $342.24M+24.0% | $275.91M-13.2% | $317.77M-23.4% | ||
| $342K-18.8% | $421K-13.9% | $489K-14.1% | $569K-6.3% | $607K-11.1% | ||
| $402.98M-10.1% | $448.37M-7.4% | $484.13M-7.0% | $520.33M-10.2% | $579.68M-6.8% | ||
| $2.51M+198% | $841K-51.2% | $1.72M-30.0% | $2.46M-27.6% | $3.4M+102% | ||
| $35.15M-6.9% | $37.74M+15.2% | $32.76M+16.7% | $28.06M+2.6% | $27.35M-10.8% | ||
| $36.81M-7.1% | $39.64M+21.0% | $32.76M+16.2% | $28.18M+1.2% | $27.84M-11.6% | ||
| $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | ||
| -$637.78M-8.4% | -$588.12M-9.4% | -$537.41M-10.4% | -$486.8M-16.8% | -$416.74M-13.2% | ||
| —— | $408.73M-9.4% | $451.37M-8.3% | $492.15M-10.8% | $551.84M-6.5% | ||
| $402.98M-10.1% | $448.37M-7.4% | $484.13M-7.0% | $520.33M-10.2% | $579.68M-6.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Cullinan Therapeutics, Inc.'s total assets?
- Cullinan Therapeutics, Inc. (CGEM) holds $403.0M in total assets, down 30.5% year over year.
- How much cash does Cullinan Therapeutics, Inc. have?
- Cullinan Therapeutics, Inc. holds $75.1M in cash and equivalents.
- Can Cullinan Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 10.28 — current assets exceed current liabilities.
- Where does Cullinan Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Cullinan Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.